Since the last World Symposium on Pulmonary Hypertension in 2008, we have witnessed
numerous and exciting developments in chronic thromboembolic pulmonary hypertension …

Despite advances in medical therapies, pulmonary arterial hypertension (PAH) continues to
cause significant morbidity and mortality. Although the right ventricle (RV) can adapt to an …

Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

Abstract The ACR Incidental Findings Committee presents recommendations for managing
incidentally detected mediastinal and cardiovascular findings found on CT. The Chest …

Pulmonary embolism (PE) is a potentially life threatening condition requiring adequate
diagnosis and treatment. Computed tomography pulmonary angiography (CTPA) is …

Objective Chronic thromboembolic pulmonary hypertension is surgically treated through
pulmonary endarterectomy. Although pulmonary endarterectomy is the treatment of choice …

The first World Health Organization (WHO) Symposium on Pulmonary Hypertension was
held in 1973 in response to the sudden increase in the number of patients with primary …

Хроническая тромбоэмболическая легочная гипертензия (ХТЭЛГ)—прекапиллярная
форма легочной гипертензии, при которой хроническая обструкция крупных и средних …

Introduction Recent studies suggest that up to 50% of patients surviving pulmonary
embolism (PE) may suffer from post-PE syndrome, which is defined by persistent dyspnea …

Background Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
may develop after a pulmonary embolism event. A ventilation-perfusion scan is …